We Put 8 Questions to Sanofi’s CEO About the Race for a Vaccine

With just eight months under his belt as chief executive officer of Sanofi, Paul Hudson finds himself racing the clock to come up with a vaccine to combat the Covid-19 pandemic, and the stakes are massive: A successful shot is the key to the global exit strategy from lockdowns.

The U.S. government, which Hudson describes as a “model” partner, is shouldering some of the risk. Should the drugmaker succeed, the U.S. will likely be first in line to get it due to that support, Hudson said in an interview this week with Bloomberg News. Other regions, he said, may follow only days or weeks later. The company said later that it’s committed to making a vaccine accessible to everyone.